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A 19-year-old woman presented with Kayser-Fleischer ring in her corneas and sunﬂower cataracts in
both eyes. There were no coexisting neurologic or hepatic symptoms, both brain magnetic resonance
imaging (MRI) and abdominal echo showed minimal changes. Serum copper concentration (Cu) and
ceruloplasmin were abnormal, and 24-hour urine collection showed abnormally high levels of copper
(348.0 mg/day). A diagnosis of Wilson disease was made. We report the interesting case of rare mani-
festations of Wilson disease; initially with ocular presentations without neurologic symptoms. Early
detection and treatment of Wilson disease is possible in patients with only ocular manifestations, and
can prevent a catastrophic sequel.
Copyright  2013, The Ophthalmologic Society of Taiwan. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Wilson disease (WD) is an autosomal recessive inborn error of
metabolism that results in excess copper deposition in the liver,
kidney, and other vital organs.1 The characteristic symptoms start
from hepatic and neurologic diseases, and then extend over the
entire body.1 We report a case with ocular manifestations as the
initial presentation of WD.2. Case report
A 19-year-old woman without systemic disease presented to our
clinicwith complaints of congested, red eyes and itching in both eyes
for 1month.Her visionwasunaffected. According to past and familial
history, glomerulonephritis and proteinuriawere diagnosed 10 years
ago, and were resolved during the elementary school period. Her
mother had lupus nephritis, and had proceeded to the end stage of
renal disease. The family history of Wilson disease was negative.
On ophthalmic examination, her best-corrected visual acuity
was 20/20 in the right eye and 20/15 in the left eye. Slit-lamp ex-
aminations showed mild congestion on bilateral conjunctivas.
There were characteristic copper-colored Kayser-Fleischer (K-F)
rings, encircling with the peripheral cornea, adjacent to the limbusthis article.
logy, Buddhist Tzu Chi Gen-
ad, Hualien 970, Taiwan.
e Ophthalmologic Society of Taiwin both eyes; the K-F ring was limited to the Descemet membrane
(Fig. 1). The anterior chamber was deep and clear. Bilateral
yellowish-brown opacities in the subcapsular cortex of the lens and
pupillary zone with petal-like spokes were also shown, which was
characteristic of sunﬂower cataract (Fig. 1). Other corneal exami-
nations showed increased peripheral corneal thickness with the
endothelial cell count within normal range (2966 cells/mm2 in the
right eye and 3457 cells/mm2 in the left eye) (Fig. 2).
On systemic survey, an abdominal ultrasonography revealed
mild parenchymal liver disease with otherwise normal ﬁndings.
Renal ultrasonography showed bilateral parenchymal renal dis-
eases of relatively small size in the right kidney. Laboratory studies
included a hemogram, liver function, renal function, and copper
proﬁle; these were within normal limits with the exception of the
serum copper concentration (Cu) and ceruloplasmin were below
normal range (Cu 436 ppb and ceruloplasmin 8 mg/dL, respec-
tively; normal Cu 700e1500 ppb, ceruloplasmin 17e31 mg/dL). A
24-hour urine collection showed an abnormally high level of cop-
per (348.0 mg/day; normal <60 mg/day). Brain magnetic resonance
imaging (MRI) revealed mild hyperintensity in the bilateral basal
ganglion on the T2-weighted image (Fig. 3).
According to the patient demographics, clinical manifestations,
MRI, and laboratory ﬁndings including serum ceruloplasmin, serum
copper, and 24-hour urine copper collection, the patient matched
the diagnostic criteria of Wilson disease, and she was referred to an
endocrinologist for D-penicillamine therapy.1 After 18 months of D-
penicillamine treatment, ceruloplasmin was still low (<7.5 mg/dL),
and other liver enzymes were within normal range [aspartate
aminotransferase (AST) 18 and alanine aminotransferase (ALT)an. Published by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. (A) Obvious Kayser-Fleischer ring was observed in both eyes. (B) The deposition of Kayser-Fleischer ring pigmentation was in the layer of the Descemet membrane. (C) A
sunﬂower pattern of cataract was observed in the left eye.
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amount reduced to 79.3 mg in 24-hour urine collection. The K-F ring
persisted, but there was no newly developed neurologic symptom,
and the abdominal echo showed stable parenchymal disease
without exacerbation.
3. Discussion
WD is an autosomal recessive inherited disorder of copper
metabolism, caused by impaired function of P-type adenosine tri-
phosphatase (ATPase), encoded by the ATP7B gene located on
chromosome 13q14.2 The ATP7B gene makes a protein important
for copper transport and the elimination of excess copper from the
body. Mutation of this gene prevents the transport protein from
functioning properly, allowing copper to accumulate in the liver,
brain, kidneys, and skeletal system. This defect results in excess
copper deposition in the liver, kidneys, and basal ganglia of the
brain, and leading to liver cirrhosis, renal tubular damage, and a
parkinsonian-like defect of motor function.1 At least two positive
signs in three of the following descriptions match the Sternlieb
diagnostic criteria: low serum ceruloplasmin (<22 mg/dL), neuro-
logic symptoms that cannot be attributable to any known cause,
and K-F ring.1
The presentation in this young woman indicates that the initial
ocular manifestation of WD can occur in patients without severe
systemic sequel of WD. She had a very dense K-F ring, but no
neurologic or hepatic abnormalities. Despite the abnormal copper
metabolism, she remained neurologically asymptomatic and with
normal liver function. WD has been evidenced to cause the
development of K-F ring and sunﬂower cataract; these disturbances
manifested mainly in the advanced stages of the disease. Virtually
all patients with K-F rings have neurologic manifestations.3Fig. 2. Corneal topography demonstrated that peripheral cornea thicIn a report ofWD, one-third of patients present with liver disease,
another third with neurologic manifestations, and others with psy-
chiatric and behavioral manifestations.4 In another study, 282 WD
patients were reviewed, which revealed that the most involved
dysfunction was neurologic deﬁcits (69.1%), followed by hepatic ab-
normalities (14.9%), hepatoneurologic deﬁcits (3.5%), pure psychiatric
symptoms (2.4%), and osseomuscular dysfunction (2.1%); only 5.3%
were presymptomatic.5 K-F rings are observed in association with
systemic involvement ofWD. This study further demonstrated that K-
F rings presented in neurologic involvement at 100%; in hepatic in-
volvements, 86%; and in presymptomatic patients, 59%. That is, K-F
ring was present in a lower percentage of the presymptomatic group
than theneurologic and/orhepatic involvements inpatientswithWD.
K-F ring is uncommon as one of the initial manifestations ofWD.
Sullivan et al6 have reported a patient with K-F ring who was
otherwise healthy. Sunﬂower cataracts are relatively rare in pa-
tients with WD, occurring in only 17% in one study.7 Taly et al5
reported an asymptomatic K-F ring prevalence of 3% in all WD
patients. K-F ring and sunﬂower cataract usually developed as a
result of excess copper accumulation in these tissues. Interestingly,
the lack of a typical clinical presentation of WD, a nearly normal
morphologic picture of the liver on ultrasonography, and only mild
hyperintensity in bilateral basal ganglion on the T2-weighted im-
age on brain MRI in our patient indicated that the symptoms of WD
appeared at the initial stages. Nevertheless, low plasma levels of
ceruloplasmin, increased plasma levels of copper, and an increased
urine excretion of copper conﬁrm the diagnosis of WD.
Other causes of K-F ring other than WD include cholestasis,
primary biliary cirrhosis, and cryptogenic cirrhosis.8 Serum bilirubin
level can exclude these diagnoses. Anticopper therapy induces KF
regression in some patients; however, one study showed that no
signiﬁcant correlations were observed between KF regression andkness increased in both eyes (Pentacam HR, Oculus, Germany).
Fig. 3. A few areas of mild hyperintensity in the bilateral basal ganglion were found on
the T2-weighted MRI (arrow).
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clinical hepatic improvement.9,10
In conclusion, adolescent patients with WD could present with
ocular symptoms initially. Early diagnosis of asymptomatic WD
with only ocular manifestations is possibly made by ophthalmol-
ogists, and early initiation of chelation and zinc therapy can prevent
catastrophic complications.
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